Results 171 to 180 of about 242,918 (218)

Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC. [PDF]

Cancer Immunol Immunother
Liu C, Chen Y, Li X, Bai Z, Jiang M, Sheng D, Zou W, Huang R, Huang Q, Wang F, Zhu J, Sun H, Liu B, Li Z, Sun B.   +14 more
europepmc   +1 more source

Predicting acute and late toxicity in prostate cancer stereotactic ablative radiotherapy: the role of dosimetric parameters and prostate volume. [PDF]

Strahlenther Onkol
Ozyigit G, Hurmuz P, Bayatfard P, Tilki B, Yedekci Y, Yilmaz MT.   +5 more
europepmc   +1 more source

Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. ¹⁷⁷Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812-21. [PDF]

Eur Urol Open Sci
Achard V, Zilli T, Tombal B.
europepmc   +1 more source

Organs at risk proximity in central lung stereotactic ablative radiotherapy: A comparison of four-dimensional computed tomography and magnetic resonance-guided breath-hold delivery techniques. [PDF]

Phys Imaging Radiat Oncol
Giraud N, Tekatli H, Schneiders FL, van Sornsen de Koste JR, Marzo M, Palacios MA, Senan S.   +6 more
europepmc   +1 more source

Simulation-Omitting and Using Library Patients for Pre-Planning Online Adaptive Radiotherapy (SUPPORT): A Feasibility Study for Spine Stereotactic Ablative Radiotherapy (SAbR) Patients. [PDF]

Cancers (Basel)
Wang D, Kim H, Zhuang T, Visak JD, Cai B, Parsons DDM, Jiang S, Godley AR, Lin MH.   +8 more
europepmc   +1 more source

Low-Dose Cyclophosphamide Enhances the Tumoricidal Effects of 5-Day Spacing Stereotactic Ablative Radiotherapy by Boosting Antitumor Immunity. [PDF]

Cancer Res Treat
Kim H, Chun SJ, Sun S, Cho H, Kim TJ, Lee YJ, Chie EK, Yang K, Kim MS.   +8 more
europepmc   +1 more source

Surgery or radiotherapy for early-stage cancer study (SORT) target trial protocol: stereotactic ablative radiotherapy (SABR) with curative intent versus surgical resection for early-stage non-small cell lung cancer (NSCLC). [PDF]

BMJ Open
Kagenaar E, Lugo-Palacios DG, Hutchings A, Aggarwal A, O'Neill S, Rachet B, Edwards J, Faivre-Finn C, Grieve R, Surgery or Radiotherapy Study (SORT) group.   +9 more
europepmc   +1 more source

Pulmonary oligometastases: Metastasectomy or stereotactic ablative radiotherapy?

Radiotherapy and Oncology, 2013
Stereotactic ablative radiotherapy (SABR; or stereotactic body radiotherapy, SBRT) emerges as treatment option for pulmonary oligometastatic disease (OMD), but there are no studies comparing SABR with pulmonary metastasectomy (PME). We analysed consecutive patients referred via a university-hospital based multidisciplinary team.Patients were offered ...
Harry J M Groen, Joachim Widder, Johannes A Langendijk   +2 more
exaly   +5 more sources

A national dosimetry audit for stereotactic ablative radiotherapy in lung

Radiotherapy and Oncology, 2017
A UK national dosimetry audit was carried out to assess the accuracy of Stereotactic Ablative Body Radiotherapy (SABR) lung treatment delivery.This mail-based audit used an anthropomorphic thorax phantom containing nine alanine pellets positioned in the lung region for dosimetry, as well as EBT3 film in the axial plane for isodose comparison.
Distefano, Gail, Lee, Jonny, Jafari, Shakardokht, Gouldstone, Clare, Baker, Colin, Mayles, Helen, Clark, Catharine H.   +6 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Implementation of Stereotactic Ablative Radiotherapy (Stereotactic Body Radiotherapy)

Clinical Oncology, 2012
The National Radiotherapy Implementation Group report, Guidelines for commissioners, providers and clinicians in England 2011, on stereotactic body radiotherapy (SBRT) [1] defined SBRT as ‘the precise irradiation of an image defined extra cranial lesion associated with the use of high radiation dose delivered in a small number of fractions’. Previously,
P, Kirkbride, P J, Hoskin
openaire   +2 more sources